Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TTD vs GSK✓SelectedUSD · GSKTTD vs GSK performance historyLatest closeAs of-5.42%11/16
Stock and ETF performance explorer

TTD vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-86.7%
GSK return
+46.9%
Excess return
-133.6%
Maximum drawdown
-91.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.4%-0.1%-5.3%-5.4%
7D-0.7%-1.3%+0.6%-0.6%
30D+21.3%+2.7%+18.5%+21.1%
3M+4.9%+2.7%+2.2%+4.7%
6M-29.9%+3.3%-33.2%-30.0%
YTD-60.9%+6.5%-67.4%-61.4%
1Y-64.6%+10.7%-75.3%-65.2%
3Y-77.6%+64.4%-142.0%-79.5%
5Y-86.7%+46.7%-133.4%-89.8%
All-86.7%+46.9%-133.6%-89.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling